AGORACOM News Flash

AGORACOM Wire - Wednesday February 15th, 2012

Breaking News ....

Lomiko (LMR: TSX-V) to Complete 43-101 Report on Previous Drilling at the Quatre Milles Graphite Property *CLIENT* Read More

Top Sector Stories ....

Strike Graphite Corp. (TSXV:SRK) Acquires Wagon Graphite Project in Quebec in Vicinity of Timcal's Lac des Iles Graphite Mine *CLIENT* Read More | Profile

Strike Graphite goes "Beyond the Press Release"

McLaren Resources (CNSX:MCL) Drills 7.0 Grams Gold Over 7.4 Metres at the TimGinn Property Located Adjacent to the Hollinger Mine *CLIENT* Read More | Watch Beyond the Press Release

DONNER METALS INTERVIEW: David Patterson Discusses the Bracemac-McLeod Mine Development Beyond the Press Release

AGORACOM Launches GraphiteStocksBlog.com

We're proud to announce the launch of GraphiteStocksBlog.com a website dedicated to the needs of investors and companies in the fast growing Graphite industry.

INAUGURAL GRAPHITE SPONSORS

Message: Medicago to participate at prominent U.S. vaccine conference

Reply New Message

« Prev Message Back To Forum Go to Threaded View Next Message »

alcollard

Rank: [?]

President

Points: [?]

12753

Rating: [?]

Votes: 140 Score: 3.6

Currently 3.7/5 Stars.

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

Medicago to participate at prominent U.S. vaccine conference

posted on Aug 13, 08 04:55AM

QUEBEC CITY, Aug. 13 /CNW/ - Medicago Inc. (TSX-V: MDG) today announced that it will be presenting an update of its development of H5N1 vaccines generated from plant-made VLPs and unique technology platform, at the Targeted Immunotherapeutics and Vaccine Summit. This conference will be held from August 13-15, 2008, at the Royal Sonesta Hotel, Cambridge, Massachusetts.

Manon Couture, Ph.D., Project Leader, Product Development and Innovation will deliver a presentation on \"Innovative Influenza Virus-Like Particles Provides Protection against an H5N1 Challenge\" in a session entitled \"Innovating Vaccine Development,\" on Thursday August 14, 2008 at 10:45 a.m. EDT.

Additional information about the Targeted Immunotherapeutics and Vaccines Summit, including the full scientific program, can be viewed at http://www.healthtech.com\">www.healthtech.com

Reply New Message

« Prev Message Back To Forum Go to Threaded View Next Message »